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Summary
Ufd1 mediates ubiquitin fusion degradation by asso-
ciation with Npl4 and Cdc48/p97. The Ufd1-ubiquitin
interaction is essential for transfer of substrates to
the proteasome. However, the mechanism and speci-
ficity of ubiquitin recognition by Ufd1 are poorly
understood due to the lack of detailed structural in-
formation. Here, we present the solution structure of
yeast Ufd1 N domain and show that it has two distinct
binding sites for mono- and polyubiquitin. The struc-
ture exhibits striking similarities to the Cdc48/p97 N
domain. It contains the double-psi  barrel motif,
which is thus identified as a ubiquitin binding do-
main. Significantly, Ufd1 shows higher affinity toward
polyubiquitin than monoubiquitin, attributable to the
utilization of separate binding sites with different af-
finities. Further studies revealed that the Ufd1-ubiq-
uitin interaction involves hydrophobic contacts sim-
ilar to those in well-characterized ubiquitin binding
proteins. Our results provide a structural basis for a
previously proposed synergistic binding of polyubiq-
uitin by Cdc48/p97 and Ufd1.*Correspondence: pamela_silver@dfci.harvard.edu (P.A.S.); gerhard_
wagner@hms.harvard.edu (G.W.)Introduction
Regulated protein degradation through the ubiquitin-
proteasome pathway has been shown to be involved in
a number of biologically important processes, such as
development, cell cycle progression, and cancer (Ad-
ams, 2004; Cook and Tyers, 2004; Dou et al., 2003;
Zhang and Laiho, 2003). Previous studies of this impor-
tant pathway provided insights into the enzymatic
mechanisms of substrate ubiquitination and subse-
quent degradation by the proteasome (Adams, 2003;
Imai et al., 2003; Passmore and Barford, 2004; Pickart,
2004). However, the molecular mechanisms responsible
for the recognition of ubiquitinated proteins and pro-
cesses leading to proteasome-mediated degradation
are currently ill-defined. An important mediator of these
intermediate pathways is the essential 40 kDa protein
Ufd1. It was originally discovered in screens of Sac-
charomyces cerevisiae mutants with defects in the
ubiquitin fusion degradation pathway (Johnson et al.,
1995). Although Ufd1 is conserved throughout eukary-
otes, its structure is not known, and it has no recogniz-
able sequence homology with other proteins of known
structure (Johnson et al., 1995).
Functionally, Ufd1 is best known for its association
with the nuclear transport protein Npl4 (Meyer et al.,
2000). This heterodimer is a founding member of a
growing family of adaptor proteins that direct an AAA-
ATPase (ATPases associated with diverse cellular activ-
ities), Cdc48 (p97 in mammals), to specific cellular
functions (see Figure 1A for the proposed association
topology). The group of adaptors includes p47 and
Vcip135, which collaborate with p97 and syntaxin 5 to
promote Golgi membrane fusion (Uchiyama et al.,
2002). In particular, p47 and the Ufd1-Npl4 complex
bind p97 in a mutually exclusive manner (Meyer et al.,
2000). However, the functions and binding modes of
many of these adaptor proteins have yet to be iden-
tified.
A series of experiments have placed the Ufd1-Npl4-
Cdc48/p97 (UNC) complex on the path between ubiq-
uitination and degradation in two well-studied pro-
cesses: endoplasmic reticulum-associated degradation
(ERAD) and regulated ubiquitin-mediated processing
(RUP) (Bays and Hampton, 2002; Jarosch et al., 2003).
ERAD is a quality control pathway in which misfolded
proteins in the endoplasmic reticulum (ER) are retro-
translocated to the cytosol and degraded by the pro-
teasome. The ERAD-substrate proteins are transferred
through the ER membrane and are polyubiquitinated on
the cytoplasmic face of the ER membrane. UNC recog-
nizes the polyubiquitinated proteins and then directs
them to the proteasome for degradation. In contrast,
RUP involves specific proteasome-mediated regulatory
cleavage of the target proteins. In yeast, for example,
membrane-tethered transcription factors Spt23 and
Mga2 are cleaved off the membrane by a proteasome-
mediated process. Here, UNC is involved in the cleav-
age of the substrates and the later release of the
Structure
996Figure 1. Structure, Sequence Alignment, and p97 Association of Ufd1
(A) Schematic model of the Ufd1-Npl4-p97 complex based on the 6-fold symmetry of the p97 AAA-ATPase. See text for the domain names.
(B) Ensemble of backbone traces of the 15 lowest-energy conformers of Ufd1. Regular secondary structured regions are aligned and overlaid
to generate the ensemble.
(C) Ribbon diagram of the lowest-energy conformer of the ensemble showing the presence of the two separate domains. The Nn subdomain
is in red, and the Nc subdomain is in blue. Secondary structural elements are numbered. The two psi loops (psi1 and psi2) in the double-psi
β barrel are also labeled. The position of the V94 found in ufd1-1 is shown.
(D) Structure-based sequence alignment of Ufd1, its orthologs, and the p97 N domain. The alignments within the Ufd1 orthologs were
generated with the ClustalX program. The alignment of p97 to the rest of the sequences is based on the experimental structure of S. cerevisiae
Ufd1 reported here and the mouse p97 N domain structure reported previously (Dreveny et al., 2004) and differs from a previously proposed
alignment (Golbik et al., 1999). The conserved residues are in red and boxed in blue, with the strictly conserved residues in all of the
sequences in inverse shading in red. The secondary structure cartoon (red) above the alignment is for the yeast Ufd1, and the one below
(blue) is for p97. The residue numbering above the alignment is for the S. cerevisiae sequence used in this study. The gene bank accession
numbers of the sequences used are: S. ser, gi1717964; H. sap, gi12053683; M. mus, gi2501439; C. ele, gi2501440; A. tha, gi42573225;
S. pom, gi3123677; p97, gi14488635.cleaved transcription factors. UNC has other known p
2roles in nuclear envelope assembly, the degradation of
IκB, and the disassembly of the mitotic spindle (Cao et
ial., 2003; Hetzer et al., 2001; Hu, 2003). However, less
mechanistic information is available on UNC’s functions r
Ain these processes.
A lack of atomic level information on the Ufd1-Npl4 i
Ucomplex and its individual components has hampered
our understanding of its diverse functional roles and e
sits interaction with p97. Recently, the structure of the
complex between p97 and one of its adaptor proteins, c47, was reported (Dreveny et al., 2004; Yuan et al.,
004).
The structure provided insights into the adaptor-p97
nteraction, especially regarding how p47 targets p97
ather than NSF, another closely related AAA-ATPase.
dditionally, a recent report addressed a possible bind-
ng mechanism between p97 and the adaptor proteins,
fd1-Npl4 and p47 (Bruderer et al., 2004). However, no
xperimental structure is available for Ufd1, although
equence analyses suggested that it contains a so-
alled double-psi β barrel motif (Golbik et al., 1999).
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N-terminal portion of Ufd1 contains a ubiquitin binding
site, whereas the C-terminal region is important for
binding Npl4 and Cdc48 (Ye et al., 2003).
Here, we report the solution structure of the N-ter-
minal fragment of Ufd1 containing residues 1–208 and
its modes of ubiquitin binding. The structure of Ufd1
(1–208) bears an unexpected and striking resemblance
to the N domain of p97. Ubiquitin binding experiments
revealed that Ufd1 has distinct binding sites and affini-
ties for mono- and polyubiquitin. These results shed
light on the ubiquitin recognition mechanism of UNC
and the reported synergistic binding of polyubiquitin by
the N domains of Ufd1 and Cdc48/p97.
Results and Discussion
Identification of the N and C Domains of Ufd1
In order to target our structural studies, we analyzed
the amino acid sequence of Ufd1 and consulted previ-
ous functional studies to search for domains and their
boundaries. Prediction of Ufd1 structural features has
been difficult since it bears little sequence similarity to
other proteins of known structure. However, the N-ter-
minal segment was predicted to contain a so-called
double-psi β barrel (Golbik et al., 1999). Functional
studies with deletion mutants of Ufd1 revealed that the
N-terminal UT3 portion (residues 1–211) contains a
binding site for ubiquitin, whereas the C-terminal UT6
fragment (residues 215–307) encompasses the binding
sites for both Npl4 and Cdc48 (Hetzer et al., 2001; Ye
et al., 2003).
Based on these results, we investigated the feasibil-
ity of obtaining structural information for Ufd1 by run-
ning 1D NMR spectra of the full-length protein as well
as N- and C-terminal fragments (representing residues
1–208 and 209–361, respectively). The C-terminal por-
tion of Ufd1 appears largely unstructured with a narrow
resonance dispersion, whereas the N-terminal portion
showed a well-dispersed spectrum characteristic of a
folded domain, suitable for NMR studies (data not
shown). Unfortunately, the full-length protein was ill be-
haved and not suitable for further structural studies.
Therefore, we focused our structural and ubiquitin
binding studies on the N-terminal fragment of Ufd1.
The Structure of the Ufd1 N-Terminal Fragment
Reveals Homology to N Domains of AAA-ATPases
The structure of the Ufd1 N-terminal fragment was de-
termined by following established multiple resonance
NMR protocols (Figure 1B). More than 97% of the back-
bone resonances and most of the side chain reso-
nances were assigned. Structural constraints were ob-
tained from an array of isotope-edited NOESY spectra
on uniformly and selectively labeled protein samples.
The structures were calculated by using a variety of
NOE distance constraints and TALOS-derived angle
constraints. The final 15 lowest-energy structures had
an average backbone rmsd of 0.66 Å for the regular
secondary structure elements. No distance constraint
violations over 0.3 Å and no angle violations larger than
3° were present in the calculated structures. The qualitycheck of the structures with PROCHECK NMR software
showed good statistics in the backbone phi-psi angle
distribution. The statistical summary of the calculation
is listed in Table 1.
The Ufd1 N-terminal fragment is composed of two
readily identifiable subdomains designated as Nn and
Nc subdomains (Figures 1B and 1C). The Nn subdo-
main adapts a double-psi β barrel fold (Castillo et al.,
1999), and the Nc subdomain has a mixed α/β roll
structure. Surprisingly, the overall structure of our Ufd1
fragment is very similar to the previously reported
structures of the N domains of p97 and other homolo-
gous AAA-ATPases (Coles et al., 1999; Yu et al., 1999;
Zhang et al., 2000). Therefore, from here forward, we
call the N-terminal fragment of Ufd1 the N domain. To
visualize this similarity, we overlaid the structures of the
N domains of Ufd1 and p97 (see Figure 2). The back-
bone rmsd for the regular secondary structural parts
are 1.838 Å (entire N domain), 1.707 Å (Nn subdomain),
and 1.283 Å (Nc subdomain), indicating that the two
proteins have similar overall domain folds. There was a
prediction that Ufd1 Nn contains a double-psi β barrel
(Golbik et al., 1999). This motif was indeed found in our
structure, however at a different sequence location
shifted by approximately 70 residues (see below). De-
spite the observation of the double-psi β barrel, the
similarity of the entire N domains of Ufd1 and p97 is
quite unexpected, because no structural similarity be-
tween an adaptor protein and an AAA-ATPase has been
reported. To our knowledge, this structural similarity,
combined with various biochemical data, provides new
insights into the mechanism of UNC-ubiquitin binding
(see below).
The observed structural homology led us to revisitTable 1. Structural Statistics of the Calculated Structures
Number of distance constraints
All 1652
Intra or sequential 929
Medium 170
Long 492
Hydrogen bond 61
Number of dihedral angle restraints 250
(backbone f and ψ)
Rmsd from ideal covalent geometry
Bonds (Å) 0.00205 ± 0.00013
Angles (°) 0.3521 ± 0.0088
Improper torsion angles (°) 0.2523 ± 0.0170
Quality check by PROCHECK NMR (%)
Residues in most favorable regions 93.8
Residues in additional allowed regions 5.1
Residues in generously allowed regions 0.0
Residues in disallowed regions 1.1
Backbone rmsd against the mean structure (Å)
Nn subdomaina (secondary structure 0.592, 0.651
region, all)
Nc subdomainb (secondary structure 0.375, 0.598
region, all)
All (secondary structure region, all) 0.661, 0.782
a Residues 18–118.
b Residues 120–198.
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998Figure 2. Overlay of N Domains of p97 and
Ufd1
The structures of N domains from p97 (PDB
code 1S3S) and Ufd1, reported here, were
overlaid in a ribbon diagram by using the
matching residues in regular secondary
structural regions. The matching residues
are as shown in the alignment in Figure 1D.
The p97 structure is in blue, and the Ufd1
structure is in red.the previously reported sequence alignment (Figure r
w1D). Although Ufd1 does not have any readily detecta-
ble sequence similarity with other known proteins, a
tprevious report suggested that the central domain of
Ufd1 (residues 82–165) contains a double-psi β barrel A
Hdomain (Golbik et al., 1999). This motif was indeed
found, but was located at residues 13–119, within the t
tNn subdomain. The predicted central location would
encompass the interdomain linker region between the (
cNn and Nc subdomains, which is inconsistent with the
experimental structure. The revised structure-based
sequence alignment presented here (Figure 1D) is used U
as the basis for the comparison of Ufd1 and p97 N do-
a
mains (see below). M
t
uSpecificity for p47 Binding of p97 over Ufd1
The N domains of Ufd1 and p97 have very similar struc- g
mtures (Figure 2), but only that of p97 binds p47 (UBX
domain of p47) (Dreveny et al., 2004; R.I., unpublished t
adata). The crystal structure of the p97/p47 complex
(Dreveny et al., 2004) reveals that p47 binds at the inter- d
uface between the Nn and Nc subdomains of p97. Analy-
sis of the superimposed structures of p97 and Ufd1 re- H
bveals that the crucial surface residues are not
conserved in Ufd1 (Figure 3). Key elements of the inter- d
bface between p97 and p47 include F343 in the S3–S4
loop of p47 and D35, S37, V38, and I70 in the N domain u
cof p97. The latter residues of p97 are replaced with F44,
G46, K47, and G83 in Ufd1 (Figure 3B). In the Ufd1 e
ustructure, one of the key residues, F44 (corresponding
to D35 in p97), has its side chain pointing away from t
tthe Nn/Nc subdomain interface, rendering equivalent
contacts with the p47 S3–S4 loop sterically unfeasible.
tIn addition, the other residues in Ufd1 (G46, G83, and
K47 along with the intervening G45) lack the hydropho- U
sbic side chains that are crucial for the p47 and p97 in-
teraction. Another essential interaction in the p97-p47 u
acomplex is the hydrogen bond between the side chain
of N345 in the S3–S4 loop of p47 and the backbone t
ncarbonyl oxygen of E141 in p97. The E141 does not
have a corresponding residue in Ufd1 because it does u
bnot align well with Ufd1 residues (Figures 1D and 3C).
Nevertheless, it is easy to see that an equivalent hy- β
vdrogen bond is highly unlikely in the Ufd1-p47 interac-
tion, because the corresponding regions are all in- T
Uvolved in canonical hydrogen bonds in helix α5 of Ufd1
(Figure 3C). The binding between Ufd1 and p47 would bequire the breakage of the helical hydrogen bonds,
hich would lead to the disruption of the helix.
It was also noted that the p47 residues involved in
he p97 interaction are not conserved in other AAA-
TPases that do not bind p47, such as NSF and VAT.
owever, those residues are well conserved in p97 or-
hologs from human to yeast. Therefore, it is likely that
he N domains evolved into both adaptor proteins
Ufd1) and AAA-ATPases with different specific re-
ognition motifs.
fd1 Binds Mono- and Polyubiquitin at Distinct
nd Nonoverlapping Sites
ost, if not all, of the Ufd1-Npl4-mediated p97 func-
ions depend on interactions with some forms of ubiq-
itin species. In addition, previous studies have sug-
ested that both p97 and Ufd1 have individual binding
otifs for polyubiquitin, and that they bind polyubiqui-
in in a synergistic manner (Dai and Li, 2001; Rape et
l., 2001; Ye et al., 2003). For both Ufd1 and p97, the N
omains have been shown to be responsible for the
biquitin binding (Dai and Li, 2001; Ye et al., 2003).
owever, there are no obvious sequence homologies
etween Ufd1, p97, and other known ubiquitin binding
omains that could provide details about the ubiquitin
inding sites. It is now well established that mono-
biquitination and polyubiquitination represent distinct
ellular signaling pathways (Haglund et al., 2003; Meyer
t al., 2002; Pickart, 2000). Therefore, determining the
nderlying differences between mono- and polyubiqui-
in binding by p97 or Ufd1 should help us understand
he function of the UNC complex.
To address the mechanism of Ufd1-ubiquitin interac-
ion, we carried out NMR binding experiments on the
fd1 N domain with mono- and polyubiquitin. We ob-
erved chemical shift changes of 1H-15N crosspeaks
pon addition of mono- or polyubiquitin (Figures 4A
nd 4C). When the affected residues are identified in
he structure, they are localized within two distinct and
onoverlapping surface regions (Figure 4B). Polyubiq-
itin binding residues are located in the regions formed
y the psi-2 loop, helix 2, sheet 3, sheet 6, and the α2–
4 loop, whereas the monoubiquitin binding site in-
olves residues in sheet 2, psi-1 loop, and helix 3.
herefore, our results confirm previous reports that
fd1 N domain binds polyubiquitin and show that the
inding sites are located in the N-terminal double-psi β
Structural and Binding Studies on Ufd1
999Figure 3. p47 Interaction with N Domains of Ufd1 and p97
(A) Schematic diagrams of possible interactions between p47 and N domains of Ufd1 and p97. “X” represents no interaction, and “O”
represents real interaction.
(B) The residues in the Nn subdomain of p97 involved in the hydrophobic interactions with F343 of p47 are shown in blue, and the correspond-
ing residues in Ufd1 are shown in red. For G46 and G83 in Ufd1 lacking the side chain heavy atoms, bonds between the Hα-Cα are shown.
(C) The residue (E141) in the Nc subdomain of p97 involved in the hydrogen bond with N345 in p47 is shown in blue. The hydrogen bond is
indicated with a dashed line. Residues in the corresponding region in Ufd1 are drawn in red. In (B) and (C), the p97 is in blue and the Ufd1 is
in red.barrel domain (Nn subdomain) (Figure 4B). These data
identify the double-psi β barrel as a ubiquitin binding
domain.
Ufd1 Has Higher Affinity for Polyubiquitin
than Monoubiquitin
The binding experiment reveals that Ufd1 has a higher
affinity for polyubiquitin than monoubiquitin (Figures 4A
and 4C). Figure 4C shows representative peak shifts at
mono- and polyubiquitin binding sites after adding the
corresponding ubiquitin species. When the same mass
amount of total ubiquitin was used, polyubiquitin
caused significant changes in peak positions in the
polyubiquitin binding sites (shown for I88; blue peaks
versus yellow peaks in the right panel), whereas mono-
ubiquitin did not elicit any appreciable changes (black
peaks versus yellow peaks in both panels) (Figure 4C).
Obviously, the average concentration of the polyubiqui-
tin is much less than that of the monoubiquitin sample
due to the larger molecular weight (see the inset of Fig-ure 4A). These more pronounced changes in the peak
positions in the Ufd1-polyubiquitin mixture clearly indi-
cate Ufd1’s higher affinity for polyubiquitin than for
monoubiquitin. Nevertheless, when a higher concentra-
tion of monoubiquitin was used, sizable changes were
observed as well (shown for I37; red peaks versus yel-
low peaks in the left panel; see also Figure 4A). Signifi-
cantly again, the changes were localized only at the
monoubiquitin binding site. These data suggest that
monoubiquitin also binds Ufd1 when present at high
concentration.
Due to the heterogeneous nature and possible multi-
ple binding sites on polyubiquitin, we could not esti-
mate the Kd values for polyubiquitin. The Kd for the
Ufd1-monoubiquitin interaction was estimated to be in
the 1–2 mM range. Although this affinity seems low, it
is comparable to the affinities of other well-known ubiq-
uitin binding domains lying within the several hundred
micromolar Kd range (Hicke and Dunn, 2003). In an ex-
treme case, a Kd value of 2.4 mM was reported in a
Structure
1000Figure 4. Different Binding Sites and Affinities of the Nn Subdomain of Ufd1 to Mono- versus Polyubiquitin
(A) Backbone amide chemical shift changes in 1H-15N HSQC spectra of Ufd1 upon adding mono- or polyubiquitin. Black squares, Ufd1 and
polyubiquitin binding; red crosses, Ufd1 and monoubiquitin binding. The values of each point represent the differences in the peak chemical
shift values from the spectra with either mono- or polyubiquitin against those from the control spectrum (Ufd1 only). The combined chemical
shift change values were calculated by using the equation in the experimental section. The concentration of monoubiquitin was 4 mM (high).
800 M concentration (low) did not produce any significant changes (not shown here; see Figure 4C). For polyubiquitin, the same mass
amount of total ubiquitin was used as for the experiment with low concentration of monoubiquitin (800 M). Therefore, in comparison, the
total mass amount of monoubiquitin is five times larger than the concentration of ubiquitin domains in polyubiquitin. The horizontal dotted
line indicates the cutoff values used to identify the binding sites. The inset gel picture shows the composition of the ubiquitin samples
analyzed by SDS-PAGE; molecular weight marker (lane 1), the monoubiquitin (lane 2), and the polyubiquitin sample (lane 3). The asterisk in
lane 2 indicates the band for E2-25K.
(B) Binding site mapping onto the calculated structure of Ufd1. The binding site for monoubiquitin (MonoUb) is in red, and that for polyubiquitin
(PolyUb) is in blue. The beginning and end residues of the major binding regions for PolyUb (left) and for MonoUb (right) are numbered in the
corresponding color.
(C) Representative overlaid HSQC spectra showing the differential binding affinities and sites. Four spectra are overlaid in each panel: yellow,
Ufd1 alone; black, with monoubiquitin (low, 800 M); red, with monoubiquitin (high, 4mM); blue with polyubiquitin (low, 800 M of total
monoubiquitin concentration). I37 (left panel in red) represents the site unique to monoubiquitin binding, and I88 (right panel in blue) represents
the site unique to polyubiquitin binding. The virtually indistinguishable peak positions of the yellow and black peaks (in all two panels)
compared with the significant changes between the yellow and blue peaks (right panel) show the differential binding affinities for mono-
versus polyubiquitin. Note that the total mass amount of ubiquitin in the blue and the black spectra is the same.
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1001possible intramolecular interaction between the UbL
domain, a close relative of ubiquitin, and the UBA1 do-
main (Ryu et al., 2003).
Intriguingly, p97, whose N domain is very similar to
that of Ufd1, has also been shown to have different af-
finities for ubiquitin species depending on the chain
lengths (Dai and Li, 2001). However, whether p97 binds
monoubiquitin remains controversial (Dai and Li, 2001;
Rape et al., 2001). Based on the observed Ufd1-mono-
ubiquitin binding and the similar structure of Ufd1 and
the p97 N domain, it is very likely that p97 also binds
monoubiquitin, although with weaker affinity than poly-
ubiquitin.
It is well established that Ufd1 is involved in protein
degradation via the polyubiquitin pathway. Now, we
show that Ufd1 can also bind monoubiquitin by using
a different recognition motif from that for polyubiquitin.
Monoubiquitination signaling has been implicated in re-
ceptor endocytosis or DNA repair (Haglund et al., 2003;
Pickart, 2000). Thus, Ufd1 might be involved in these
processes through monoubiquitin binding. Although
the modulation of the p97 activities with different adap-
tors seems to provide some explanation for the myriad
of unrelated activities of p97, there are still mysteries
about the exact mechanism of the diversity of the p97
functions. Ufd1’s binding to both mono- and polyubiq-
uitin could suggest at least partial answers to these
questions. It may be speculated that further modulation
of the adaptor-p97 complex depending on mono- or
polyubiquitin binding would provide another layer of di-
versity to the functions of the complex.
The Degradation-Impaired Phenotype
of the ufd1-1 Strain
Our suggestion of the double-psi β barrel as a ubiquitin
binding domain is also consistent with the phenotypic
changes of a single point mutant yeast strain. Johnson
et al. (1995) reported that a yeast strain with the V94D
missense mutation in UFD1 (ufd1-1) has impaired deg-
radation of the normally short-lived UbV76-V-B-gal.
Now, this phenotype can be linked to the failure in ubiq-
uitin-mediated protein degradation in the Ufd1 path-
way. Our structure shows that the mutated V94 is at
the very hydrophobic core of the double-psi β barrel,
forming numerous hydrophobic contacts with other
core residues (see Figure 1C for the position of V94).
Therefore, it is likely that the introduction of a charged
residue (Asp) at this hydrophobic core leads to destabi-
lization and/or misfolding of the β barrel domain fold,
which would impair ubiquitin binding and degradation
of substrate proteins.
Ufd1 Nn Subdomain Recognizes a Well-Conserved
Binding Motif in Monoubiquitin
After defining the ubiquitin binding sites on Ufd1, we
pursued to identify the Ufd1 binding sites on ubiquitin.
We recorded 1H-15N-correlated NMR spectra of 15N-
labeled ubiquitin before and after addition of unlabeled
Ufd1. The changes of ubiquitin resonance positions
upon addition of Ufd1 are shown in Figure 5A.
Similar to the situation in Ufd1, the chemical shift
changes are localized to a contiguous region of the
ubiquitin surface (Figure 5B). Significantly, the residuesaffected by Ufd1 binding are either in or very close to
the hydrophobic patch on the ubiquitin surface involv-
ing L8, I44, and V70 (Figures 5A and 5B). It is well-
established that this hydrophobic region is involved in
interactions between monoubiquitin and other ubiquitin
binding domains, such as UBA, CUE, and NZF domains
(Alam et al., 2004; Cook et al., 1994; Kang et al., 2003;
Yuan et al., 2004). The monoubiquitin binding sites on
the Ufd1 side are also mostly hydrophobic, involving
residues C27, Y28, I30, A31, M32, I37, K39, W99, M100,
M101, and G109 (residues above threshold in Figure
4A). Therefore, the mapping data suggest that the bind-
ing between monoubiquitin and Ufd1 involves specific
hydrophobic interactions, similar to those in the above
well-studied cases.
Ufd1-Ubiquitin Interaction: The Dual Binding
Site Mechanism
Our Ufd1 structure and ubiquitin binding results sug-
gest a new mechanism for ubiquitin recognition. A
ubiquitin binding protein may use a single domain that
contains two different sites for mono- and polyubiquitin
with different affinities. The different binding affinity be-
tween mono- and polyubiquitin for a single ubiquitin
binding domain has actually been demonstrated in
other systems. For example, the UBA domain binds
mono- and polyubiquitin with affinities that differ by two
orders of magnitude (Raasi et al., 2004).
However, the reason for the enhanced affinity for poly-
ubiquitin over monoubiquitin is still poorly understood.
As pointed out previously, a simple explanation based
on an increased number of binding sites did not provide
a satisfactory answer (Pickart, 2000). Instead, new in-
teraction surfaces formed in polyubiquitin species are
likely to be the underlying mechanism. Particularly, poly-
ubiquitin has one less positive charge around the K-48
than monoubiquitin due to the formation of the isopep-
tide bond. Although we currently don’t know the confor-
mation of the isopeptide bond in polyubiquitin, it may be
speculated that the electrostatic difference between
monoubiquitin and polyubiquitin has a role in the ob-
served differential binding of the ubiquitin species.
As the solution and crystal structures revealed, poly-
ubiquitin (here, di- or tetraubiquitin) can exist in dif-
ferent conformations (Cook et al., 1992, 1994; Phillips
et al., 2001; Varadan et al., 2004). Therefore, the re-
cognition motifs that the various ubiquitin species pre-
sent to the binding partner can be different depending
on their conjugation or polymerization status (Pickart,
2000). Furthermore, a simple accessibility mechanism
could not explain the higher affinity of the UBA domain
for diubiquitin over monoubiquitin, because the sug-
gested binding sites are less accessible in the diubiqui-
tin case (Varadan et al., 2004).
The above-described findings suggest that a more
involved mechanism is responsible for the enhanced
affinity of the polyubiquitin species. The presence of
two different binding sites with different affinities, as in
Ufd1, might be one of the mechanisms. This dual bind-
ing site mechanism is more likely for the larger ubiquitin
binding domains such as the UEV domain (about 145
residues) than for the smaller domains (less than 50 res-
idues) such as UIM, NZF, and UBA due to the require-
ment of two separate binding sites.
Structure
1002Figure 5. Binding Sites on the Ubiquitin Molecule
(A) Chemical shift changes of the ubiquitin backbone resonance peaks upon addition of Ufd1 are plotted against the residue numbers. The
horizontal dotted line indicates the cutoff values used to identify the binding sites. The asterisks on residue 9 and 75 indicate that the
corresponding peak residues disappeared completely upon addition of Ufd1. The bar heights of those residues were taken from the highest
values within the particular binding motif. Hydrophobic binding motifs found in other interactions involving ubiquitin are shown at the upper
part of the graph (see text).
(B) The residues involved in Ufd1 binding are colored in red on the ribbon structure of the ubiquitin reported previously (PDB code: 1D3Z).
The side chains of the residues in the “hydrophobic patch” (see text) are indicated in blue, and the K48 is shown in green.In fact, the dual binding site mechanism seems re- o
Nlated to an interesting observation reported previously
for the UEV domain. VanDemark et al. (2001) solved the u
mcrystal structure of the UEV/E2 complex and mapped
the binding site of the diubiquitin molecule as coupled
through a Lys63 linkage. The diubiquitin binding sites,
however, were found to be very different from the mono-
ubiquitin binding site in a related UEV-monoubiquitin
complex reported recently (Sundquist et al., 2004). As
pointed out in the latter paper, the UEV domains in both
reports share the same fold. Therefore, the UEV domain
may represent another example for the usage of dis-
tinct sites in binding different ubiquitin forms.
A Model for the Synergistic Binding
of Polyubiquitin to Ufd1 and p97
As mentioned above, the N domains of p97 and Ufd1
are structurally similar, and both have N-terminal
double-psi β barrels. The N domains are similar not only
structurally but also functionally. They both bind mo-
noubiquitin and polyubiquitin and have higher affinity
for the latter. Therefore, we suggest that similar regions
in the double-psi β barrel account for the mono- or po-
lyubiquitin binding properties in both p97 and Ufd1
(Figure 6). With these assumptions, we can propose a
simple model for the synergistic binding to polyubiqui-
tin by Ufd1 and p97 (Figures 1A and 6). Ufd-1 binds,
through its C domain, the N domain of p97 (the Ufd1-
Npl4 interaction also occur through the C domain of
Ufd1 [Hetzer et al., 2001]). This binding puts the double- F
t
psi β barrels of Ufd1 and the p97 in close proximity,
Bproviding avidity for synergistic binding to polyubiq-
e
uitin. l
Additional synergy might be gained due to the hex- u
uameric nature of p97 (see Figure 1A). The six N domainsight bend around the hexamer for binding with higher
igure 6. Schematic Diagrams of the Mono- and Polyubiquitin In-
eractions by p97 and Ufd1 N Domains
indings are indicated with arrows. Solid lines, interactions with
xperimental evidence; dotted lines, suggested interactions; red
ines, interactions addressed in this report. For blue lines in p97-
biquitin interactions, binding regions are inferred from the Ufd1-
biquitin interactions.f p97 in one complex can, in theory, bind six Ufd1-
pl4 molecules, providing a large capacity for poly-
biquitin association. Then, the polyubiquitin chain
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bind p97 in 6 to 6 stoichiometry at saturation conditions
in vitro, although the crystal structure of the same com-
plex contained fewer adaptor molecules per hexamer
(Dreveny et al., 2004). Overall, the avidity-driven binding
due to the proximal positioning of the double-psi β bar-
rels and the multimeric nature of the UNC complex may
be part of the mechanism of the synergistic binding of
polyubiquitin to p97 and Ufd1.
Experimental Procedures
NMR Sample Preparation
DNA encoding S. cerevisiae Ufd1 residues 1–208 was amplified
from yeast genomic DNA (by using sense primer 5#-GGAATTCCA
TATGTTTTCTGGCTTTAGTTC-3# and antisense primer 5#-GGCCTG
ATCATTATTTGTAATCCGGTTCC-3#) and cloned into the Nde1 and
BamH1 sites of Invitrogen pET15b vector (pET15b-Ufd1N). An
E. coli strain (codonPlus, Stratagene, La Jolla) was transformed
with pET15b-Ufd1N. The transformed E. coli were grown in M9-
based minimal media at 37°C and induced at OD600 = 0.6 with IPTG
(50 M) for 15 hr. 15N-, 15N/13C-, and 2H/15N/13C-labeled protein
samples were prepared by using correspondingly labeled ammo-
nium chloride (>99% 15N), glucose (>99% U-13C), and deuterium
oxide (>99.9% 2H). The protein was purified with Ni-NTA affinity
chromatography followed by anion-exchange chromatography,
when necessary. All protein concentrations were determined from
absorbance at 280 nm, by using extinction coefficients calculated
from the primary sequence. In some preparations, the his-tag was
cleaved with PreScission protease (Amersham, Piscataway), but
the spectrum remained essentially the same with noncleaved pro-
tein, and the spectra from both preparations were used indiscrimi-
nately. Typical NMR samples contained approximately 200 M pro-
tein in 20 mM phosphate buffer (pH 6.0) with 95% H2O and 5%
D2O, containing 50 mM NaCl and 0.01% NaN3. All of the spectra
were obtained at 34°C.
NMR Spectroscopy
NMR data were acquired by using Bruker DRX 500, Bruker DRX
600, or Varian Unity Plus 750 machines equipped with gradient tri-
ple resonance probes. All the triple resonance experiments for
backbone resonance experiments were obtained by using the
Bruker DRX 500 spectrometer with a cryogenic probe.
Sequential assignments of the backbone resonances were ob-
tained by using HNCA, HN(CO)CA, HNCO, and HN(CA)CO with deu-
terated and/or nondeuterated protein samples. Side chain assign-
ments were obtained by using H(CCO)NH, C(CO)NH, and HCCH-
TOCSY spectra. For distance constraints, 15N-separated, 13C-sep-
arated NOESY-HSQC, 15N-separated HSQC-NOESY with corre-
spondingly labeled samples, and 4D-13C-HMQC-NOESY-HSQC,
4D-13C,15N-HMQC-NOESY-HSQC were obtained with 15N-labeled,
deuterated, ILV-methyl-13C-protonated samples (Gross et al.,
2003). In the 4D NOSEY spectra, 13C sweep widths were set to
those of the methyl carbons. Mixing times of 90 ms and 180 ms
were used for protonated and deuterated samples, respectively.
Because of the severe crowding of the aromatic region caused by
the large number of phenylalanines, we recorded 15N-HMQC-
NOESY spectra on deuterated samples that contained isoleucine,
leucine, and valine residues that were 13C-labeled and protonated
at the methyl positions but deuterated elsewhere. In addition, the
samples contained protonated phenylalanine or tyrosine residues.
The spectra were recorded with the indirect spectral width set to
that of the methyl region for high-resolution aromatic-methyl proton
NOE analysis. All raw data were processed with nmrPipe (Delaglio
et al., 1995) and were analyzed with nmrview (Johnson and Blevins,
1994) software.
Structure Calculation
The 3D protein structure was calculated based on various experi-
mentally derived NOE constraints and TALOS angle restraints (Cor-
nilescu et al., 1999). Peak intensities were categorized into strong,
medium, weak, and very weak, with upper distance bounds set to3.4, 4.0, 5.5, and 6.5 Å, respectively. Standard pseudoatom correc-
tions were applied as needed. The lower distance bounds were set
to 1.8 Å in all distance categories. Hydrogen bond constraints de-
rived from the amide proton deuterium exchange experiment were
used to constrain the NH-O distance to 2.8 Å. For helical regions,
canonical hydrogen bond patterns were also used to constrain the
NH-O to 2.8 Å. Initial structures were obtained by using the CYANA
program (Guntert et al., 1997), and the final structures were calcu-
lated by using the CNS program (Brunger et al., 1998), implement-
ing the conformational databases and the secondary chemical shift
database described earlier (Kuszewski et al., 1995, 1996, 1997).
The 15 lowest-energy conformers were picked to represent the en-
semble structure, and the lowest-energy conformer was used for
all of the figures. These 15 conformers do not have any NOE viola-
tions greater than 0.3 Å or angle violations larger than 3°.
Ubiquitin Binding Experiment
The rabbit E1 and E2-25K enzymes were purchased from Boston
Biochem (Boston, MA), and the ubiquitin was purchased from
Sigma (bovine ubiquitin, St. Louis, MO) and VLI research (human
ubiquitin, Malvern, PA). The E2-25K synthesizes only the K-48-
linked chains. Polyubiquitin chains were synthesized by using the
method described previously with slight changes (Chen et al.,
1991). Briefly, ubiquitin was incubated with E1 (1.35 g) and E2-
25K (3 g) in 50 l conjugation buffer (20 mM Tris-HCl [pH 7.6], 20
mM KCl, 5 mM MgCl2, 1 mM DTT, and 10 mM ATP) at 37°C for 20
hr. The monoubiquitin sample was prepared with the same ingredi-
ents, except ATP. All the ubiquitin samples were buffer exchanged
to the Ufd1 NMR sample buffer with a PD-10 gel filtration cartridge.
NMR binding experiments were carried out by mixing 100 l 13C-
15N double-labeled Ufd1 with 140 l mono- or polyubiquitin (Ufd1
final concentration = 120 M). All of the samples were prepared
from a single-batch preparation of Ufd1. In control experiments
without ubiquitin, the presence of buffer and enzyme species did
not cause any changes in the spectra. The backbone amide peak
positions from the spectrum with the E1, E2, and other components
for polyubiquitination reaction were identical to those from the con-
trol spectrum (Ufd1 only), showing that those additional compo-
nents do not bind Ufd1 (data not shown). The combined chemical
shift changes (in ppm) were calculated by (δHN2 + [0.17δ15N]2)−,
where δHN and δ15N are the chemical shift changes for the amide
protons and the amide nitrogens, respectively (Park et al., 2002).
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